In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

As global markets show signs of optimism with cooling inflation and strong earnings reports, major U.S. stock indexes have rebounded, particularly favoring value stocks over growth shares. In this ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

The global vision care products market is projected to reach USD 103.7 billion by 2032, growing at a CAGR of 6.21%. This growth ...

According to the American Academy of Ophthalmology, glaucoma is a group of eye conditions that damage the optic nerve, often ...

Aaron Wealth Advisors LLC cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and ...

Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,460,000 ...

Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with ...

As we age, our bodies go through many changes, and one area that deserves extra attention is blood sugar control. Blood sugar, or glucose, is the body’s main source of energy, but when it gets too ...

The incorporation of Lisinopril 20 milligrams to the basic list of medicines for patients with arterial hypertension prompted ...